User: Guest  Login
Document type:
Meeting Abstract
Author(s):
Lorenzen, S; Porschen, R; Al-Batran, SE; Hofheinz, R; Thuss-Patience, P; Möhler, M; Grabowski, P; Arnold, D; Greten, T; Müller, L; Gerecke, U; Rothling, N; Schuster, T; Peschel, C; Lordick, F
Title:
Addition of the monoclonal Epidermal Growth Factor (EGF) receptor antibody cetuximab (E) to cisplatin/5-FU (CF) versus CF in 1st line Metastatic Squamous Cell Carcinoma of the esophagus (MESCC): First results of the phase II oesotux trial
Journal title abbreviation:
Onkologie
Year:
2008
Journal volume:
31 Suppl.
Pages contribution:
91-91
Language:
eng
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/18322411
Print-ISSN:
0378-584X
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX